WO2007143586A3 - Composition for wound care and method of using same - Google Patents

Composition for wound care and method of using same Download PDF

Info

Publication number
WO2007143586A3
WO2007143586A3 PCT/US2007/070271 US2007070271W WO2007143586A3 WO 2007143586 A3 WO2007143586 A3 WO 2007143586A3 US 2007070271 W US2007070271 W US 2007070271W WO 2007143586 A3 WO2007143586 A3 WO 2007143586A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
wounds
enhancing
treating
localized
Prior art date
Application number
PCT/US2007/070271
Other languages
French (fr)
Other versions
WO2007143586A2 (en
Inventor
Brian C Giles
Original Assignee
Pharmaionx Inc
Brian C Giles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaionx Inc, Brian C Giles filed Critical Pharmaionx Inc
Publication of WO2007143586A2 publication Critical patent/WO2007143586A2/en
Publication of WO2007143586A3 publication Critical patent/WO2007143586A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

This invention encompasses an expeditious method and composition for treating a wide variety of wounds and injuries by promoting the elevation of pH at the site of injury, enhancing the reduction or elimination of pain and scaring from the patho-physiological process of infection proliferation, and promoting enhanced wound care management and wound healing. The invention also provides a method of treating a subject having a condition associated with the presence of free radicals in quantities sufficient to cause undesirable symptoms. The invention encompasses controlling mechanisms of intracellular and extra-cellular ionic physiology through the administration of a composition which includes alkaline salts preferably cesium salts, for pH modulating and for restoring and enhancing the localized cellular ionic physiology. The composition promotes the increase of the electrical current density to certain types of wounds and also functions to treat and/or prevent adhesions resulting from surgeries. The composition simultaneously normalizes the localized ionic environment, thereby normalizing immune responses and reducing acidotic induced pain.
PCT/US2007/070271 2006-06-01 2007-06-01 Composition for wound care and method of using same WO2007143586A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80998406P 2006-06-01 2006-06-01
US60/809,984 2006-06-01
US87985707P 2007-01-11 2007-01-11
US60/879,857 2007-01-11

Publications (2)

Publication Number Publication Date
WO2007143586A2 WO2007143586A2 (en) 2007-12-13
WO2007143586A3 true WO2007143586A3 (en) 2008-03-27

Family

ID=38802269

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/070271 WO2007143586A2 (en) 2006-06-01 2007-06-01 Composition for wound care and method of using same

Country Status (1)

Country Link
WO (1) WO2007143586A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140194803A1 (en) * 2011-07-28 2014-07-10 Regents Of The University Of Minnestoa Wound-healing compositions and method of use
CN105435232A (en) * 2014-08-08 2016-03-30 深圳君圣泰生物技术有限公司 Liquid preparation composition and preparation method and use and solid preparation thereof
CA3085466A1 (en) 2017-12-11 2019-06-20 Animal Ethics Pty Ltd Wound dressing

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563184A (en) * 1983-10-17 1986-01-07 Bernard Korol Synthetic resin wound dressing and method of treatment using same
US6312713B1 (en) * 1998-06-12 2001-11-06 Bernard Korol Polymer matrices for storage and sustained release of drugs and chemicals
US20020034554A1 (en) * 1999-12-16 2002-03-21 Tsung-Min Hsu Dual enhancer composition for topical and transdermal drug delivery
US20050244344A1 (en) * 2004-04-12 2005-11-03 Brian Giles Compositions for oral hygiene and method for using same
US20060029682A1 (en) * 2001-11-29 2006-02-09 Greystone Medical Group, Inc. Treatment of wounds and compositions employed

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563184A (en) * 1983-10-17 1986-01-07 Bernard Korol Synthetic resin wound dressing and method of treatment using same
US6312713B1 (en) * 1998-06-12 2001-11-06 Bernard Korol Polymer matrices for storage and sustained release of drugs and chemicals
US20020034554A1 (en) * 1999-12-16 2002-03-21 Tsung-Min Hsu Dual enhancer composition for topical and transdermal drug delivery
US20060029682A1 (en) * 2001-11-29 2006-02-09 Greystone Medical Group, Inc. Treatment of wounds and compositions employed
US20050244344A1 (en) * 2004-04-12 2005-11-03 Brian Giles Compositions for oral hygiene and method for using same

Also Published As

Publication number Publication date
WO2007143586A2 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
EA201690745A1 (en) METHODS OF TREATMENT AND PREVENTION OF THE DISEASE "TRANSPLANTATE AGAINST THE OWNER"
BRPI0905073A2 (en) Implantable drug depot to reduce, prevent or treat pain in a patient in need of such treatment and method for treating acute pain.
WO2006116621A3 (en) Methods for treating eye conditions
WO2011028965A3 (en) Antimicrobial medical dressings and protecting wounds and catheter sites
WO2007130892A3 (en) Method for treatment of constipation-predominant irritable bowel syndrome
BRPI0904955A2 (en) Implantable drug depot to reduce, prevent or treat pain in a patient in need of such treatment and methods for treating acute pain and for making an implantable drug depot.
WO2007100675A3 (en) Collagenase for treating cellulite
HK1082203A1 (en) Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
ATE533486T1 (en) USE OF PYRIDONE DERIVATIVES FOR PREVENTING AND TREATING RADIATION-RELATED LUNG INJURY
CY1111536T1 (en) METHODS AND COMPOSITIONS FOR DESTRUCTION OF CROP CELLS
MX2007008764A (en) Methods for treating adhesive capsulitis.
BR0214481A (en) Method and composition for potentiation of an opioid analgesic
TR201901744T4 (en) Tourmaline-based, sanitary towels for women and urinary incontinence, and gauze / bandages and surgical dressings for treating wounds.
WO2008090287A3 (en) Use of at least one botulism neurotoxin for treating the pain induced by therapeutic treatments for the aids virus
IS8186A (en) Treatment for post-operative pain relief
AU2018236629A8 (en) Hydrogel patch
EP2080496A2 (en) Post-operative protective garment for animals
DE602004011051D1 (en) METHOD FOR THE TREATMENT OF DISORDERS WITH HSP90-INHIBITING AGENTS COMBINED WITH ANTIMETABOLITES
WO2007143586A3 (en) Composition for wound care and method of using same
EA200700739A1 (en) CLOSTRIDIAL NEUROTOXINS USED TO TREAT THE TISSUE
WO2016060917A3 (en) Formulations for histatin therapeutics
MX2015015379A (en) Alpha adrenergic agonists for in the treatment of tissue trauma.
WO2007100590A3 (en) Methods for treating cellulite
Simpson et al. Use of a gentamicin‐impregnated collagen sheet (Collatamp®) following implantation of a sacral nerve stimulator for faecal incontinence
EA201290827A1 (en) OPHTHALMOLOGICAL SOLUTION FOR THE TREATMENT OF EYE INFECTION, CONTAINING THE HEADLOOK FOXES OF THE OTHER HEADS, OR ITS SALT, OR SOLVAT OF THESE CONNECTIONS, THE METHOD OF TREATING THE EYE INFECTION, LEVOFLOXACINE OR THE EFFICIENT CONFIGURATIONS

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07798035

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07798035

Country of ref document: EP

Kind code of ref document: A2